Literature DB >> 2070709

Nutritional model of hepatocarcinogenesis. Rats fed choline-devoid diet.

B Lombardi1, N Chandar, J Locker.   

Abstract

Rats fed a choline-devoid diet as the sole treatment develop hepatocellular carcinomas, the pathogenesis of which appears to reside exclusively in effects of the diet on the liver. Among the latter, most prominent is the induction of repeating cycles of liver cell injury, death, and regeneration. Two other models have been described recently in the literature, in which development of hepatic neoplastic lesions occurs after protracted periods of liver cell injury, death, and regeneration, without exposure of the animals to chemical carcinogens. The possibility is considered that an abnormal increase in cell turnover may result in all of the genomic alterations that are required for initiation, promotion, and neoplastic transformation of liver cells in these models of hepatocarcinogenesis. The possible involvement, in the same models, of endogenously initiated liver cells also is discussed briefly.

Entities:  

Mesh:

Year:  1991        PMID: 2070709     DOI: 10.1007/BF01297151

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Regulation of liver growth: protooncogenes and transforming growth factors.

Authors:  N Fausto; J E Mead
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

Review 2.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Immortal epithelial cells of normal C3H mouse liver in culture: possible precursor populations for spontaneous hepatocellular carcinoma.

Authors:  G H Lee; N Sawada; Y Mochizuki; K Nomura; T Kitagawa
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

4.  Choline Deficiency, Partial Hepatectomy, and Liver Tumors in Rats and Mice.

Authors:  Paul M Newberne; Joao Lauro V de Camargo; Anthony J Clark
Journal:  Toxicol Pathol       Date:  1982-02       Impact factor: 1.902

5.  Liver cell turnover in rats fed a choline-devoid diet.

Authors:  N Chandar; J Amenta; J C Kandala; B Lombardi
Journal:  Carcinogenesis       Date:  1987-05       Impact factor: 4.944

Review 6.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

7.  Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.

Authors:  S N Zaman; W M Melia; R D Johnson; B C Portmann; P J Johnson; R Williams
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

8.  The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens.

Authors:  A K Ghoshal; E Farber
Journal:  Carcinogenesis       Date:  1984-10       Impact factor: 4.944

9.  Hepatocarcinogenesis in rats fed methyl-deficient, amino acid-defined diets.

Authors:  Y B Mikol; K L Hoover; D Creasia; L A Poirier
Journal:  Carcinogenesis       Date:  1983-12       Impact factor: 4.944

10.  High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis.

Authors:  R Masuda; M C Yoshida; M Sasaki; K Dempo; M Mori
Journal:  Jpn J Cancer Res       Date:  1988-07
View more
  3 in total

1.  Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet.

Authors:  Ian Guest; Zoran Ilic; Stewart Sell
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 2.  Choline nutrition programs brain development via DNA and histone methylation.

Authors:  Jan Krzysztof Blusztajn; Tiffany J Mellott
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

3.  Hypomethylation of DNA: a possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis.

Authors:  J I Goodman; J L Counts
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.